Regarding "Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic" - Hinpetch Daungsupawong; Viroj Wiwanitkit (Taylor & Francis Group, 2024)